Northstar Asset Management Inc. Lowers Stock Position in Danaher Corporation $DHR

Northstar Asset Management Inc. lessened its holdings in shares of Danaher Corporation (NYSE:DHRFree Report) by 59.3% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,999 shares of the conglomerate’s stock after selling 7,271 shares during the period. Northstar Asset Management Inc.’s holdings in Danaher were worth $952,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Main Street Group LTD purchased a new position in Danaher during the 1st quarter valued at about $25,000. N.E.W. Advisory Services LLC purchased a new stake in Danaher in the second quarter worth about $25,000. JPL Wealth Management LLC purchased a new stake in Danaher in the third quarter worth about $25,000. WFA of San Diego LLC bought a new position in shares of Danaher during the second quarter valued at approximately $26,000. Finally, Hilton Head Capital Partners LLC purchased a new position in shares of Danaher during the fourth quarter valued at approximately $27,000. 79.05% of the stock is currently owned by institutional investors.

Danaher Trading Up 0.3%

Shares of NYSE DHR opened at $216.41 on Friday. The firm’s 50 day moving average price is $199.46 and its 200-day moving average price is $192.52. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The company has a market cap of $152.13 billion, a PE ratio of 38.44, a P/E/G ratio of 2.69 and a beta of 0.78.

Danaher (NYSE:DHRGet Free Report) last announced its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. During the same quarter last year, the firm earned $0.77 earnings per share. The firm’s quarterly revenue was up 5.5% compared to the same quarter last year. On average, equities research analysts expect that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on DHR. Stifel Nicolaus dropped their price target on Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a research report on Wednesday, July 22nd. HSBC reduced their price objective on Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a research report on Wednesday, June 3rd. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $240.00 price objective on shares of Danaher in a research note on Wednesday, July 22nd. Guggenheim cut their target price on Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. Finally, Wells Fargo & Company reduced their price target on Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a report on Wednesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $228.91.

Get Our Latest Research Report on DHR

Danaher Company Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Recommended Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.